Xenon Pharmaceuticals Inc.’s Post

We’re super excited to share that Abigail Graham, Associate Director, will be attending this year’s European Academy of Neurology Congress in Helsinki, Finland! Abigail is looking forward to joining discussions surrounding the recent developments in precision diagnosis, specifically the developments in headache from Teva Pharmaceuticals and AbbVie, and rare disease by Roche. She will also be joining talks surrounding how climate change contributes to the progression of neurological conditions such as sleep and stress. Keep an eye out for the team’s key insights from the congress, coming soon! #EANCongress2024 #EAN2024 #EAN #neurology #neuroscience #rarediseases #headache #climatechange #marketresearch #neurologicalconditions #sleep #stress #congress #attending #healthcaremarketresearch #marketresearch #research #pharmaceuticalmarketresearch #pharmamarketresearch #MRX

Let's meet and discuss the latest developments in Neuro diseases. Me and my colleague Prof. Xanthopoulos shall introduce you to the extended capabilities and the reliable network that Accelsiors CRO offers. #ADPD2024 #clinicalresearch #alzheimers #parkinsons #neuroscience

Accelsiors is continuing to support #ADPD with our attendance in Lisbon, this March 2024.   Meet our colleague Thani Pavlidou, Business Development Director to gain insights into our trusted network of neurology sites and investigators.   She will be happy to share with you the outcomes of the most recent feasibility data in #Alzheimer’s and #Parkinson’s diseases and all the key methods to achieve success in your clinical trials.   #ADPD2024  #clinicalresearch #clinicaltrials #biomarkers #neurology #neuroscience

Part-2️⃣ in Clinical Kidney Journal by Oxford University Press 📚 The first review of this series described how CKD could represent a risk factor for adverse drug reactions affecting the central nervous system 🧠. This second review will describe some of the most common medications associated with cognitive impairment and describe their effects. https://lnkd.in/di44SHPp CONNECT COST Action COST Association - European Cooperation in Science and Technology Gaye Hafez, Jolanta Malyszko, Aleksandra Golenia, Aleksandra Klimkowicz-Mrowiec, Ana Carina Ferreira, Mustafa Arıcı, Annette Bruchfeld, Dorothea Nitsch, Ziad A Massy, Marion PEPIN, Giovambattista Capasso, Laila-Yasmin Mani, Sophie liabeuf #pharmacology #nephrology #neurology #chronickidneydisease #cognitiveimpairment #euprojects #neuroscience #cognitivefunction

Did you know? The first 3D cerebral organoid was generated by Lancaster et al. (https://lnkd.in/gBSiumeh) in 2013! Today, Epiloid assesses the electrical and cellular activity of these organoids to improve drug development in neurology. These organoids can be used across the drug development pipeline, from identifying personalized medicine, to designing safer drug trials, to reducing unnecessary harm in animal drug testing! Pictured below is a close-up image of one of these organoids under a microscope! Interested in learning more about us? Head to our website for more information: www.epiloid.com. #funfact #bio #neurology

📢 Call For Papers: Neurodegenerative Diseases We are calling for contributions to an article collection dedicated to emerging insights on clinical and research questions that may guide the future of these therapeutics in AD. We will consider original research articles, brief reports, and review articles focusing on, but not strictly limited to biological mechanisms of action of anti-amyloid drugs, epidemiological studies addressing the critical issue of patient selection, economic implication and healthcare system planning and advanced neuroimaging techniques with a specific focus on amyloid-related imaging abnormalities (ARIA). 📅 Deadline: December 15, 2023 Learn more and submit here 👉 https://ow.ly/fVIW50Pryoi #KargerPublishers #publishing #CallForPapers #Neurology #Neuroscience

🔬Exploring pain-targeting compounds? Our team conducts in vitro/in vivo assays on non-human neurons, spinal slices, and human sensory cells (native or iPSC-derived) to accelerate your pain drug discovery. Contact us at https://lnkd.in/g8_xmiXw to initiate a discussion about your ongoing research. #pain #painresearch #sodiumchannels #paindrugdiscovery #painkillers #neuroscience #preclinical #drugdiscovery

It’s an honor to be ranked #3 out of 21 companies for corporate reputation among patient groups familiar with Lundbeck in the field of neurology, as shared in the PatientView 2022 Corporate Reputation of Pharma: Neurology Edition. The report is based on survey results from 286 neurology patient groups worldwide, providing invaluable #pharmainsights based on their expertise. This recognition is meaningful and a testament to our commitment to restoring brain health so every person can be their best. Read the full release by PatientView here: https://bit.ly/3MmB0kv #neurology #brainhealth #neuroscience

🔥 EAN 2024 Meeting Begins This Week! 🔥 The European Academy of Neurology Congress 2024, starting on June 29th, 2024, will spotlight groundbreaking research across key neurological fields. A total of 2,777 abstracts have been submitted, showcasing the latest research and advancements in neurology treatment and care. 🔴 Multiple Sclerosis (MS) leads the charge with the highest number of abstracts, followed by Parkinson's, Stroke, Migraine and Myasthenia Gravis 🔴 As the most discussed indication at this year’s EAN Congress, MS research is showcasing advances in diagnosis, treatment, and patient care. From innovative biomarkers to novel therapies, the scientific community is making tremendous strides in understanding and managing this complex neurological condition. For congress coverage or post-EAN intelligence question follow-ups, email us at 📥 info@atacana.com #EAN2024 #Neuroscience #Neurology #pharma #biotech #MulipleSclerosis #Migraine #ParkinsonDisease #MyastheniaGravis

As we advance our work to the clinic to bring patients therapeutic options for #neurodegenerativediseases, we at Muna Therapeutics have serious fun, every day - check out the video clip below! #muna_tx #neuroscience #neurodegeneration #alzheimersdisease #parkinsonsdisease #multiplesclerosis #biotech #neurology